Beta-adrenergic potentiation of the increased in vitro accumulation of cycloleucine by rat thymocytes induced by triiodothyronine

The Journal of Clinical Investigation
J EtzkornS H Ingbar

Abstract

We have previously demonstrated that 3,5,3'-triiodothyronine (T(3)), whether administered in vivo or added to suspending media in vitro, promptly stimulates the in vitro accumulation of the nonmetabolized amino acids, alpha-aminoisobutyric acid, and cycloleucine (CLE) by thymocytes isolated from weanling rats. In these studies, we have examined the in vitro interaction between catecholamines and T(3) with respect to this effect. The previously reported enhancement of CLE accumulation in thymocytes by T(3) in vitro (1 muM) was confirmed. When added alone in concentrations ranging between 10 nM and 0.1 mM, the adrenergic agonists, epinephrine and norepinephrine, had no effect on CLE accumulation. At a concentration of 1 muM, isoproterenol, terbutaline, and phenylephrine were also without effect. However, the effect of T(3) was clearly potentiated by the concomitant addition of epinephrine, norepinephrine, and possibly isoproterenol, whereas terbutaline and phenylephrine were without effect. Neither basal nor T(3)-enhanced CLE accumulation was affected by the addition alone of the adrenergic blocking agents, propranolol (0.1 mM), phentolamine (10 muM), or practolol (0.1 mM). Nevertheless, the beta(1)- and beta(2)-antagonist, propr...Continue Reading

References

Oct 1, 1980·European Journal of Clinical Pharmacology·O R NilssonL Tegler
Jan 1, 1990·Thyroid : Official Journal of the American Thyroid Association
Oct 1, 1980·Journal of the American Geriatrics Society·S R GambertE M Dagon
Apr 30, 1981·Biochemical and Biophysical Research Communications·P J Davis, S D Blas
Jan 1, 1980·Endocrine Research Communications·K Yoshida, P J Davis
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·O R Nilsson, B E Karlberg

Citations

May 15, 1975·The New England Journal of Medicine·H L Bleich, E S Boro
Nov 7, 1977·Biochemical and Biophysical Research Communications·N B Pliam, I D Goldfine
May 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·H SeoS Refetoff
Mar 1, 1979·The Journal of Clinical Investigation·J Segal, S H Ingbar
Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·H H HagedornM K Bohm
Sep 1, 1967·The Journal of Clinical Investigation·M Vaughan
Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·B M BabiorR S Kipnes
Oct 1, 1949·Proceedings of the Society for Experimental Biology and Medicine·S N MARDER

Related Concepts

Z-Max
2-aminoisobutyric acid
T-Lymphocyte
Practolol
Amino Acids, I.V. solution additive
Antagonist Muscle Action
Thymocyte
Catecholamines Measurement
Puromycin Dihydrochloride
Adrenergic Agonists

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.